These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies on the elimination of bufotenin in urine. Sireix DW; Marini FA Behav Neuropsychiatry; 1969 Aug; 1(5):29-31. PubMed ID: 5398115 [No Abstract] [Full Text] [Related]
4. Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders. Takeda N; Ikeda R; Ohba K; Kondo M Neuroreport; 1995 Nov; 6(17):2378-80. PubMed ID: 8747157 [TBL] [Abstract][Full Text] [Related]
5. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"]. Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A Encephale; 1969; 58(4):360-76. PubMed ID: 5378191 [No Abstract] [Full Text] [Related]
6. Hysteria and schizophrenia. Saavedra JM Lancet; 1970 Nov; 2(7682):1090. PubMed ID: 4098388 [No Abstract] [Full Text] [Related]
7. [Values of bufoteninuria in non-hospitalized schizophrenics and epileptics]. Poch GF; Spatz H; Fischer E Prensa Med Argent; 1967 Apr; 54(9):409-10. PubMed ID: 5602623 [No Abstract] [Full Text] [Related]
8. Studies on psychobiological correlations apparent in urine. Research through so-called Kraepelinketoenol test (KKT) in neuropsychiatry. Shinozaki K; Furutani M Hiroshima J Med Sci; 1968 Sep; 17(3):197-219. PubMed ID: 5717119 [No Abstract] [Full Text] [Related]
9. Psychiatric disorders in a developing community as reflected by archival material. Gijana EW; Louw J S Afr Med J; 1981 Jun; 59(27):988-91. PubMed ID: 7244912 [TBL] [Abstract][Full Text] [Related]
10. Significance of hydroxyskatole and mauve factor excretion in schizophrenia. Sohler A; Renz RH; Smith S; Kaufman J Int J Neuropsychiatry; 1967 Aug; 3(4):327-31. PubMed ID: 6064120 [No Abstract] [Full Text] [Related]
11. Bufotenine in human urine. Sireix DW; Marini FA Biol Psychiatry; 1969 Apr; 1(2):189-91. PubMed ID: 5368977 [No Abstract] [Full Text] [Related]
14. Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia. Emanuele E; Colombo R; Martinelli V; Brondino N; Marini M; Boso M; Barale F; Politi P Neuro Endocrinol Lett; 2010; 31(1):117-21. PubMed ID: 20150873 [TBL] [Abstract][Full Text] [Related]
15. The clinical significance of an elevated excretion of xanthurenic acid in psychiatric patients. Hoes MJ Acta Psychiatr Belg; 1979; 79(6):638-46. PubMed ID: 162316 [TBL] [Abstract][Full Text] [Related]
16. Methylated psychotogens in the urine of psychiatric patients. Kanabus P; Krysa G; Matsumoto H; Stencka K Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608 [No Abstract] [Full Text] [Related]
17. [Quantitative determination of bufotenin in urine of normals and mental patients]. Spatz H Prensa Med Argent; 1967 Nov; 54(38):2116-7. PubMed ID: 5613517 [No Abstract] [Full Text] [Related]
18. Diurnal patterns of 17-hydroxy-corticosteroid excretion in psychiatric illness. Ellman GL; Blacker KH Dis Nerv Syst; 1969 Oct; 30(10):683-8. PubMed ID: 5355300 [No Abstract] [Full Text] [Related]
19. Psychiatric illness in the families of convicted criminals: a study of 519 first-degree relatives. Guze SB; Wolfgram ED; McKinney JK; Cantwell DP Dis Nerv Syst; 1967 Oct; 28(10):651-9. PubMed ID: 6051292 [No Abstract] [Full Text] [Related]